Group items tagged

This mechanism supports basic research to increase knowledge/understanding through discovery and hypothesis generation, and should focus on providing basic fundamental knowledge that will inform and enable the future development of novel autonomous and/or robotic medical systems to care for wounded soldiers/patients through breakthrough, exploratory research. The objective is focused on addressing the following 1. Autonomous and Unmanned Medical Capability - Identify novel ideas, approaches and research towards the conceptualization of autonomous and unmanned technologies for next-generation, high-quality medical capabilities with limited or absent medical care personnel, or personnel with limited skills. Research novel concepts, plausible approaches and advanced concept designs using biologically inspired cognitive computing models, machine learning, artificial intelligence, soft robotic semi-autonomous/autonomous resuscitation concepts and advanced applications of information sciences among other innovative, exploratory research towards advancing the state-of-the-art in delivery of forward resuscitative care at the point of injury. 2. Medical Robotics Research - Identify novel ideas, approaches and research towards the conceptualization of medical robotics and real-time tele-presence capabilities exploring the limits of machine perception for tele-robotic semi-autonomous and autonomous trauma care within remote and dispersed geographic settings. This could include exploratory research in semi-autonomous robotic surgery to improve the safety profile and efficacy of tele-surgical procedures and outcomes using hard robotics in challenging situations (e.g., combat casualties on the multi-domain battlefield or mass casualty situations) and remote or austere geographic locations, among other innovative, exploratory research aims and novel concepts.

The mission of the JPC-1/MSIS is to explore the implications of models and technology for medical education and for the provision, management, and support of health services in the military. The JPC-1/MSIS plans, coordinates, and oversees a responsive world-class, tri-Service science and technology program focused on two areas of research. The first area, Medical Simulation and Training, is focused on improving military medical training through medical modeling, simulation, and educational training tools. The second area, Health Informatics and Information Technologies, is focused on improving the use and sharing of health-related data for better strategic planning, process development, and software applications.

Recently FDA launched a series of strategic efforts designed to improve the national capacity to study use and impact of medical devices in the real-world setting.  The National Evaluation System for health Technology (NEST) was created with the goals of leveraging electronic health information captured from the routine clinical use of marketed health technology.  Since in the world of medical devices today, clinical registries collect and maintain detailed, curated clinical data on millions of patients receiving diagnostics and treatments involving health technologies, they can provide critical infrastructure that can be used for a variety of analyses related to real world patient care and outcomes.  To address some of the inherent and modifiable limitations of the registries, the model of strategically Coordinated Registry Networks (CRNs) was recommended by the National Medical Device Registry Task Force (NMDRTF) and further developed by Medical Device Epidemiology Network (MDEpiNet). 

The goal of this funding opportunity announcement is to (i) foster joint activities between US and Indian scientists on affordable diagnostic and therapeutic technologies, and (ii) address medical needs in low-resource settings, taking advantage of opportunities and technological advances, to aid the development of appropriate affordable medical devices. To address needs and opportunities, Indian and U.S. scientists will undertake a coordinated program that will involve collaborative, peer-reviewed research and technology development projects. Collaboration between engineers and scientists in the U.S. and India will be based on mutual benefit, trust, and a shared commitment to development of diagnostic or therapeutic technologies for people in low-resource settings.

The goal of the Biophotonics program is to explore the research frontiers in photonics principles, engineering and technology that are relevant for critical problems in fields of medicine, biology and biotechnology.  Fundamental engineering research and innovation in photonics is required to lay the foundations for new technologies beyond those that are mature and ready for application in medical diagnostics and therapies.  Advances are needed in nanophotonics, optogenetics, contrast and targeting agents, ultra-thin probes, wide field imaging, and rapid biomarker screening. Low cost and minimally invasive medical diagnostics and therapies are key motivating application goals.

The goal of the Biophotonics program is to explore the research frontiers in photonics principles, engineering and technology that are relevant for critical problems in fields of medicine, biology and biotechnology.  Fundamental engineering research and innovation in photonics is required to lay the foundations for new technologies beyond those that are mature and ready for application in medical diagnostics and therapies.  Advances are needed in nanophotonics, optogenetics, contrast and targeting agents, ultra-thin probes, wide field imaging, and rapid biomarker screening. Low cost and minimally invasive medical diagnostics and therapies are key motivating application goals.

The goal of the Biophotonics program is to explore the research frontiers in photonics principles, engineering and technology that are relevant for critical problems in fields of medicine, biology and biotechnology.  Fundamental engineering research and innovation in photonics is required to lay the foundations for new technologies beyond those that are mature and ready for application in medical diagnostics and therapies.  Advances are needed in nanophotonics, optogenetics, contrast and targeting agents, ultra-thin probes, wide field imaging, and rapid biomarker screening. Low cost and minimally invasive medical diagnostics and therapies are key motivating application goals.

The goal of the Biophotonics program is to explore the research frontiers in photonics principles, engineering and technology that are relevant for critical problems in fields of medicine, biology and biotechnology.  Fundamental engineering research and innovation in photonics is required to lay the foundations for new technologies beyond those that are mature and ready for application in medical diagnostics and therapies.  Advances are needed in nanophotonics, optogenetics, contrast and targeting agents, ultra-thin probes, wide field imaging, and rapid biomarker screening. Low cost and minimally invasive medical diagnostics and therapies are key motivating application goals. 

NineSigma, representing a Global Leader in medical devices, invites proposals for technologies that can create micron scale structures on metal surfaces. The challenge is to obtain a robust micropatterned surface with a high aspect ratio that can maintain the surface characteristics in a high pressure, high temperature environment.  The approach must be applicable to curved (non planar) metal surfaces. Microstructures on the surfaces of medical devices have many advantages for the various medical application. Surface patterning imparts critical functional features to the device, such as anti-fouling, hydrophobicity, adhesion, etc. The RFP sponsor is seeking innovations that allow creating precise microstructured patterns on non-planar metal surfaces.

The world needs more effective, functional and affordable technology solutions to clinical medical problems. With the BMEidea competition, the nation's leading competition for biomedical and bioengineering students, we challenge students to pioneer a health-related technology that addresses a real clinical need. Competition entries are judged on: Technical, economic and regulatory feasibility Contribution to human health and quality of life Technological innovation Potential for commercialization Strong BMEidea submissions define a problem and demonstrate the development of a device, product, or technology designed to solve it. BMEidea awards are presented each year at the MD&M East Medical Device Trade Show and Convention. Competition winners will receive cash awards as well as access to resources to be used for further development and commercialization of their products. In addition, the first place institution will get to display the BMEidea trophy in their winning department for the year.

The MTEC mission is to assist the U.S. Army Medical Research and Materiel Command (USAMRMC) by providing cutting-edge technologies and effective materiel life cycle management to transition medical solutions to industry that protect, treat, and optimize Warfighters' health and performance across the full spectrum of military operations. MTEC is a biomedical technology consortium collaborating with multiple government agencies under a 10-year renewable Other Transaction Agreement (OTA), Agreement No. W81XWH-15-9-0001, with the U.S. Army Medical Research Acquisition Activity (USAMRAA). MTEC currently is recruiting a broad and diverse membership that includes representatives from large businesses, small businesses, "non-traditional" government contractors, academic research institutions and not-for-profit organizations.

To that end, the foundation welcomes applications for its Research Program, which supports pioneering discoveries in science, engineering, and medical research. Through the program, grants are awarded to research universities, medical colleges, and major private independent scientific and medical research institutions in support of projects that are focused on important and emerging areas of research; have the potential to develop breakthrough technologies, instrumentation, or methodologies; are innovative, distinctive and interdisciplinary; demonstrate a high level of risk due to unconventional approaches or by challenging a prevailing paradigm; and have the potential for transformative impact (e.g., the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem). The program seeks to fund high-risk/high-impact work that lays the groundwork for new paradigms, technologies, and discoveries, save lives, and adds to our collective understanding of the world.

This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop and translate medical technologies aimed at reducing disparities in healthcare access and health outcomes.  Appropriate medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them.  Responsive grant applications must involve a formal collaboration with a healthcare provider or other healthcare organization serving one or more health disparity populations during Phase I and Phase II.

The Loan Guaranty Service (LGY), which is an office of the Veterans Benefits Administration (VBA), Department of Veterans Affairs (VA), is announcing the availability of funds for the Specially Adapted Housing Assistive Technology (SAHAT) Grant Program. The objective of the grant is to encourage the development of new assistive technologies for specially adapted housing. Veterans Affairs acknowledges there are many emerging technologies that could improve home adaptations or otherwise enhance a Veteran's or Servicemember's ability to live independently. Therefore, VA has defined ''new assistive technology'' as an advancement the Secretary determines could aid or enhance the ability of a Veteran or Servicemember to live in an adapted home. PLEASE NOTE: SAHAT funding does not support the construction or modification of residential dwellings for accessibility. Veterans and Servicemembers interested in receiving assistance to adapt a home are encouraged to contact their local Veterans Affairs Regional Benefits Office, Regional Loan Center, or Medical Center for more information, or visit: http://www.benefits.va.gov/homeloans/adaptedhousing.asp **Note: Some documents may contain an application expiration date of February 25, 2018, that date has been extended to March 4, 2018.

Applicants must choose one of the following categories they feel their project best exemplifies: 1.) Outstanding Emerging Innovation: The winning nominee is a person or company working on the basic research phase of an innovation - for three years or less, pre-commercialization - that has received grant money or outside money and that demonstrates the potential for continued growth and success. 2.) Outstanding Bioscience Innovation: The winning nominee is a company that has achieved a significant milestone in the life sciences, including but not limited to drug therapeutics, medical devices, medical imaging and pharmacogenetics. 3.) Outstanding Information Technology Innovation: The winning nominee is a company that has achieved a significant milestone in information technology, including hardware and software, packaged applications, custom applications and digital media. 4.) Outstanding Marketing Innovation: The winning nominee is a company that has achieved a significant milestone in consumer marketing. 5.) Outstanding Advanced Engineering Innovation: The winning nominee is a company that has achieved a significant milestone in advanced engineering - where technology is used to design a product.

This Funding Opportunity Announcement (FOA) seeks clinical research focused on the development and utilization of technologies that can help address patient outcomes. Relevant areas of technology include remote healthcare delivery to patients via telehealth, robotics to enhance medication adherence, on-site (e.g., clinical or home setting) care delivery, mobile heath to increase access and adherence, web-based decision support tools, and others.  Research projects may focus on assessment, diagnosis, intervention development, or intervention implementation.  Research projects that a) incorporate emerging and cutting edge technologies to explain and predict patient trajectories, b) inform interventions, c) support real-time clinical decision making, and d) facilitate effective long-term management of chronic illness are especially needed.  Critical to this FOA, proposed research should identify specific patient outcomes expected to improve from technological approaches.  The specific tools or interventions proposed should clearly indicate how they will enhance patient benefits in environments, such as clinical settings, and/or in the home and community.

The Loan Guaranty Service (LGY), which is an office of the Veterans Benefits Administration (VBA), Department of Veterans Affairs (VA), is announcing the availability of funds for the Specially Adapted Housing Assistive Technology (SAHAT) Grant Program. The objective of the grant is to encourage the development of new assistive technologies for specially adapted housing. Veterans Affairs acknowledges there are many emerging technologies that could improve home adaptations or otherwise enhance a Veteran's or Servicemember's ability to live independently. Therefore, VA has defined ''new assistive technology'' as an advancement the Secretary determines could aid or enhance the ability of a Veteran or Servicemember to live in an adapted home.PLEASE NOTE: SAHAT funding does not support the construction or modification of residential dwellings for accessibility. Veterans and Servicemembers interested in receiving assistance to adapt a home are encouraged to contact their local Veterans Affairs Regional Benefits Office, Regional Loan Center, or Medical Center for more information, or visit:http://www.benefits.va.gov/homeloans/adaptedhousing.asp

WHO CAN APPLY? I-Corps@Ohio funds will be offered on a competitive basis to teams of faculty researchers and graduate students developing institution-based technologies from Ohio colleges and universities. Under the supervision of business and entrepreneurial mentors, teams will develop market-driven value propositions and scalable business models around their technologies and attract follow on funding to support company formation and market entry. APPLICATION PROCESS The I-Corps@Ohio proposal submission process consists of five steps: 1. mandatory meeting with the appropriate TTO representative(s) at the PI's institution; 2. team selection of technology track (science and engineering or medtech); 3. registration of all team members in the online portal; 4. proposal submission; and 5. full team interview with I-Corps@Ohio program representatives. All teams are required to complete the online profile and submission questionnaire beginning October 23, 2019. Deadline to apply is January 15, 2019. The PI may complete this information or designate another member of the team as the lead member. Subsequent members of the team will be invited to join by the lead member through the application portal and must complete his or her profile. Every effort should be made to identify all team members prior to submitting the online proposal submission questionnaire. Additional team members may be added later. You will be asked to select from two tracks: Medtech Track: Teams will select Medtech Track if the subject technology is in the form of medical devices, diagnostics, medicines, vaccines, software, testing procedures and systems and is developed to solve a health/clinical problem and improve the quality of human life. Science and Engineering (S&E) Track: Teams will select S&E Track if the technology does not fit into the Medtech category.

The goal of theBiomedical Engineering(BME)program is to provide research opportunities to develop novel ideas into discovery-level and transformative projects that integrate engineering and life sciences in solving biomedical problems that serve humanity in the long-term. BME projects must be at the interface of engineering and life sciences, and advance both engineering and life sciences. The projects should focus on high impact transformative methods and technologies. Projects should include methods, models and enabling tools of understanding and controlling living systems; fundamental improvements in deriving information from cells, tissues, organs, and organ systems; new approaches to the design of structures and materials for eventual medical use in the long-term; and novel methods for reducing health care costs through new technologies. The long-term impact of the projects can be related to fundamental understanding of cell and tissue function, effective disease diagnosis and/or treatment, improved health care delivery, or product development.

The goal of theBiomedical Engineering(BME)program is to provide research opportunities to develop novel ideas into discovery-level and transformative projects that integrate engineering and life sciences in solving biomedical problems that serve humanity in the long-term. BME projects must be at the interface of engineering and life sciences, and advance both engineering and life sciences. The projects should focus on high impact transformative methods and technologies. Projects should include methods, models and enabling tools of understanding and controlling living systems; fundamental improvements in deriving information from cells, tissues, organs, and organ systems; new approaches to the design of structures and materials for eventual medical use in the long-term; and novel methods for reducing health care costs through new technologies. The long-term impact of the projects can be related to fundamental understanding of cell and tissue function, effective disease diagnosis and/or treatment, improved health care delivery, or product development.

The purpose of this program is to develop next generation health care solutions and encourage existing and new research communities to focus on breakthrough ideas in a variety of areas of value to health, such as sensor technology, networking, information and machine learning technology, decision support systems, modeling of behavioral and cognitive processes, as well as system and process modeling. Effective solutions must satisfy a multitude of constraints arising from clinical/medical needs, social interactions, cognitive limitations, barriers to behavioral change, heterogeneity of data, semantic mismatch and limitations of current cyberphysical systems. Such solutions demand multidisciplinary teams ready to address technical, behavioral and clinical issues ranging from fundamental science to clinical practice.

The purpose of this program is to develop next generation health care solutions and encourage existing and new research communities to focus on breakthrough ideas in a variety of areas of value to health, such as sensor technology, networking, information and machine learning technology, decision support systems, modeling of behavioral and cognitive processes, as well as system and process modeling. Effective solutions must satisfy a multitude of constraints arising from clinical/medical needs, social interactions, cognitive limitations, barriers to behavioral change, heterogeneity of data, semantic mismatch and limitations of current cyberphysical systems. Such solutions demand multidisciplinary teams ready to address technical, behavioral and clinical issues ranging from fundamental science to clinical practice.

This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop and translate medical technologies aimed at reducing disparities in healthcare access and health outcomes. Appropriate medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them. Responsive grant applications must involve a formal collaboration with a healthcare provider or other healthcare organization serving one or more health disparity populations during Phase I and Phase II.

Biophotonics applies photonics technology to the fields of medicine, biology and biotechnology.  Basic research and innovation in photonics that is very fundamental in science and engineering is needed to lay the foundation for new technologies beyond those that are mature and ready for application in medical diagnostics and therapies.  Advances are needed in nanophotonics, optogenetics, contrast and targeting agents, ultra-thin probes, wide field imaging, and rapid biomarker screening.  Low cost and minimally invasive medical diagnostics and therapies are key goals. Examples of topics are: Macromolecule Markers - Innovative methods for labeling of macromolecules, new compositions of matter/methods of fabrication of multi-color probes such as might be used for marking and detection of specific pathological cells and push the envelope of optical sensing to the limits of detection, resolution, and identification Low Coherence Sensing at the Nanoscale - Low coherence enhanced backscattering (LEBS), n-dimensional elastic light scattering, and angle-resolved low coherence interferometry for early cancer detection (dysplasia) Neurophotonics - Studies of photon activation of neurons at the interface of nanomaterials attached to cells.  Development and application of biocompatible photonic tools such as parallel interfaces and interconnects for communicating and control of neural networks Micro- and Nano-photonic - Development and application of nanoparticle fluorescent quantum-dots; sensitive, multiplexed, high-throughput characterization of macromolecular properties of cells; nanomaterials and nanodevices for biomedicine Optogenetics - Employing light-activated channels and enzymes for manipulation of neural activity with temporal precision.